← FDA Drug Approvals (Drugs@FDA)

VORICONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2023-02-02

Drug application

FDA Application #
ANDA212162
Application type
Abbreviated New Drug Application (Generic)
Brand name
VORICONAZOLE
Generic name
VORICONAZOLE
Active ingredients
VORICONAZOLE
Dosage form
POWDER
Route
INTRAVENOUS
Marketing status
Discontinued
Sponsor
EUGIA PHARMA
Manufacturer
Eugia US LLC
First approval
2023-02-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown